Today: 30 June 2026

Berkshire Hathaway stock price: BRK.B ends at $508 as Dow tops 50,000 — what to watch next week

Berkshire Hathaway stock price: BRK.B ends at $508 as Dow tops 50,000 — what to watch next week

NEW YORK, Feb 7, 2026, 10:22 EST — Market’s done for the day. Berkshire Hathaway’s Class B stock edged up 0.83% Friday, closing out the session at $508.09. Shares traded in a range from $502.89 to $509.66. The company, run by CEO Greg Abel and headed by chairman Warren Buffett, covers an array of sectors, from insurance to railroads, energy, and plenty of other businesses.
7 February 2026
·
1 … 491 492 493 494 495 … 2,124

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Go toTop